News

The United States is facing another potential government shutdown going into this weekend. In such an event, the Division of Corporate Finance’s operations will be extremely limited....
By: Fenwick & West LLP

As 2024 draws to a close, several crucial developments — some aimed at modernizing long-standing legal practices, others addressing emerging challenges — have reached patent law. Originally published in Law360 - December 20, 2024....

The US government recently announced another package of export controls on semiconductor manufacturing equipment designed to further curb China’s ability to produce advanced-node semiconductors that can be used in artificial intelligence and advanced computing applications....

As the landscape of U.S. immigration policy evolves with each change of Presidential Administration, employers and individuals face uncertainty and potential challenges in the areas of compliance and visa sponsorship....

The CFPB has issued a list of regulatory matters under consideration between now and October, 2025, although many of the regulatory initiatives face an uncertain future once the Trump Administration takes office....

On December 20, 2024, Alta Resources Corporation (“Alta Resources”) filed a notice of data breach with the Attorney General of Maine after discovering that there was unauthorized access to portions of its computer network.

Mississippi Bankers Association, the American Bankers Association, the Consumer Bankers Association, America’s Credit Unions, and three banks are seeking a preliminary injunction blocking the CFPB from implementing the bureau’s controversial overdraft rule finalized just a month prior to the Trum

The Beltway Buzz is a weekly update summarizing labor and employment news from inside the Beltway and clarifying how what’s happening in Washington, D.C., could impact your business....

Precedential and Key Federal Circuit Opinions - 1. CYTIVA BIOPROCESS R&D AB v. JSR CORP. [OPINION] (2023-2074, 12/4/2024) (Prost, Taranto, Hughes) - Prost, J.

As we ring in the new year, it is time, once again, to reflect on some of the most significant legal developments for drug and device companies this year. Below is a brief recap and assessment of a few of the top developments affecting drug and device law that came out of 2024....

Pages